Skip over navigation
The Hospital
Research
Support Us
Ottawa Hospital Research Institute
Home
Français
Directions & Maps
Contact Us
About Us
Vision and Strategic Directions
Board Chair and CEO Message
Leadership Team
Annual Reports
Facilities
Research Data Management
Equity, Diversity and Inclusion
Wellness
Our Research
Priorities, Programs and Diseases
Researcher Profiles
National Research Networks
Scientific Publications
Research Awards
Technology Transfer
Industry Sponsored Research
Responsible Innovation
For Students & Fellows
News & Events
Newsroom
Seminars & Events
Career Opportunities
For Patients
News & Events
Home
>
News & Events
>
Newsroom
Bookmark or Share
Display Options
Display Options
+
Increase
/
-
Decrease
font size
High contrast version
Printer-friendly version
Newsroom
Seminars & Events
Newsroom
Top researchers gather in Ottawa to advance the development of stem cell therapies for cardiovascular disease
February 13, 2012
Approximately 45 leading stem cell researchers from Ottawa and Toronto gathered at the Canadian Museum of Nature today to present and discuss their latest work in developing stem cell therapies for cardiovascular disease.
The meeting is part of the Cardiovascular Repair using Enhanced Stem Cell Therapy (CREST) project, which was awarded $4.3M in 2010 through the
Ontario Ministry of Economic Development and Innovation
’s Ontario Research Fund. This project is led by Dr. Duncan Stewart, CEO and Scientific Director of the
Ottawa Hospital Research Institute
(OHRI), Vice-President of Research at The Ottawa Hospital and Professor of Medicine at the University of Ottawa. Other partner institutions include the
University of Ottawa Heart Institute
,
St. Michael’s Hospital
, the
University Health Network
and the
University of Ottawa
, as well as a number of private sector partners.
The ultimate goal of CREST is to advance the development of new stem cell therapies to repair and regenerate the heart and blood vessels, and thus alleviate the enormous burden of cardiovascular disease in North America, which currently affects more than 71 million adults. CREST researchers are focusing on heart attack, pulmonary hypertension and acute lung injury, but their research also has implications for diseases such as stroke, kidney disease, diabetes and macular degeneration. Some therapies developed by CREST members are already being tested in human clinical trials, and several others are expected to reach the clinical trial stage within the next few years.
Today’s event includes 12 scientific lectures focusing on areas such as stem cell biology, tissue engineering, biomaterials, clinical trials, imaging, systems biology and genetic engineering. In addition, 24 trainees and research staff presented their latest research during a poster session.
For more information, please consult the following web profiles:
CREST Investigators:
Dr. Duncan Stewart
Dr. Rob Beanlands
Dr. Marjorie Brand
Dr. Kim Connelly
Dr. David Courtman
Dr. Darryl Davis
Dr. May Griffith
Dr. W. Conrad Liles
Dr. Howard Leong-Poi
Dr. Lynn Megeney
Dr. Erik Suuronen
CREST Scientific Advisory Board Members
Dr. Bernard Thebaud
Dr. Jennifer Van Eyk
Dr. Peter Zandstra
CREST Collaborators
Dr. Claudia dos Santos
Dr. Michael Kutryk
Dr. Jim Harden
Note: Patients interested in participating in clinical trials should discuss this with their personal health care provider. See
www.clinicaltrials.gov
for a searchable database of clinical trials. See
www.closerlookatstemcells.org
for a list of questions to ask when considering experimental stem cell therapies.